Logo image of AEON

AEON BIOPHARMA INC (AEON) Stock Price, Quote, News and Overview

NYSEARCA:AEON - NYSE Arca - US00791X1000 - Common Stock - Currency: USD

0.1075  +0 (+0.19%)

AEON Quote, Performance and Key Statistics

AEON BIOPHARMA INC

NYSEARCA:AEON (2/21/2025, 11:32:49 AM)

0.1075

+0 (+0.19%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High17.17
52 Week Low0.1
Market Cap3.99M
Shares37.16M
Float10.90M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PE0.15
Earnings (Next)N/A N/A
IPO10-08 2021-10-08


AEON short term performance overview.The bars show the price performance of AEON in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

AEON long term performance overview.The bars show the price performance of AEON in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of AEON is 0.1075 USD. In the past month the price decreased by -13.88%. In the past year, price decreased by -99.06%.

AEON BIOPHARMA INC / AEON Daily stock chart

About AEON

Company Profile

AEON logo image AEON Biopharma is a biopharmaceutical company focused on the development of ABP-450, a proprietary 900 kDabotulinum toxin complex, for debilitating medical conditions. The company is headquartered in Newport Beach, California and currently employs 6 full-time employees. The company went IPO on 2021-10-08. The firm is focused on developing botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions. The biologic ingredient in ABP-450 is Clostridium botulinum toxin, type A with a molecular weight of 900 kDa. Its initial development programs for ABP-450 are focused on migraine, cervical dystonia and gastroparesis. Migraine is a neurological condition characterized by recurrent episodes of headaches. The firm is developing ABP-450 for the preventative treatment of migraine, which is inclusive of both chronic migraine and episodic migraine. Cervical dystonia is a neurological condition characterized by involuntary muscle contractions of the neck which may present as spasms, contractions or abnormal posture. Gastroparesis is a gastrointestinal disorder characterized by the slowing or stoppage of movement of food and liquid from the stomach to the small intestine.

Company Info

AEON BIOPHARMA INC

4040 Macarthur Boulevard, Suite 310

Newport Beach CALIFORNIA US

Employees: 5

Company Website: https://www.aeonbiopharma.com/

Investor Relations: https://investors.aeonbiopharma.com/overview/default.aspx

Phone: 19492844555.0

AEON BIOPHARMA INC / AEON FAQ

What is the stock price of AEON BIOPHARMA INC today?

The current stock price of AEON is 0.1075 USD. The price increased by 0.19% in the last trading session.


What is the ticker symbol for AEON BIOPHARMA INC stock?

The exchange symbol of AEON BIOPHARMA INC is AEON and it is listed on the NYSE Arca exchange.


On which exchange is AEON stock listed?

AEON stock is listed on the NYSE Arca exchange.


What is the price forecast or stock price prediction for AEON BIOPHARMA INC stock?

7 analysts have analysed AEON and the average price target is 5.1 USD. This implies a price increase of 4644.19% is expected in the next year compared to the current price of 0.1075. Check the AEON BIOPHARMA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is AEON BIOPHARMA INC worth?

AEON BIOPHARMA INC (AEON) has a market capitalization of 3.99M USD. This makes AEON a Nano Cap stock.


How many employees does AEON BIOPHARMA INC have?

AEON BIOPHARMA INC (AEON) currently has 5 employees.


Should I buy AEON BIOPHARMA INC (AEON) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does AEON BIOPHARMA INC (AEON) stock pay dividends?

AEON does not pay a dividend.


What is the Price/Earnings (PE) ratio of AEON BIOPHARMA INC (AEON)?

AEON BIOPHARMA INC (AEON) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.56).


What is the Short Interest ratio of AEON BIOPHARMA INC (AEON) stock?

The outstanding short interest for AEON BIOPHARMA INC (AEON) is 27.32% of its float. Check the ownership tab for more information on the AEON short interest.


AEON Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

AEON Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to AEON. AEON may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AEON Financial Highlights

Over the last trailing twelve months AEON reported a non-GAAP Earnings per Share(EPS) of -0.56. The EPS decreased by -409.61% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -116.07%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)-409.61%
Revenue 1Y (TTM)N/A

AEON Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to AEON. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %27.32%
Short Ratio0.14
Analysts
Analysts82.86
Price Target5.1 (4644.19%)
EPS Next Y161.54%
Revenue Next YearN/A